Cor­rect­ed: West­lake tar­gets $450M for Sei­den­berg's next life sci­ences fund

Last year
Financing

Cyteir to dis­solve as on­col­o­gy biotech scraps its fi­nal clin­i­cal at­tempt two years af­ter IPO

Last year
People
R&D

CMS re­works drug price ne­go­ti­a­tion process with law­suits top of mind

Last year
Law

All eyes on Brent Saun­ders: Bausch + Lomb deal­mak­er to buy Xi­idra from No­var­tis in $1.75B deal

Last year
Deals
Pharma

Bellerophon Ther­a­peu­tics lets al­most all em­ploy­ees go, looks for deals in wake of PhI­II flop

Last year
People

PTC Ther­a­peu­tics re­ports sec­ond tri­al flop for late-stage pro­gram

Last year
R&D

Ex-Gala­pa­gos med­ical chief heads to uniQure; Mar­tin Mack­ay lines up Rally­bio suc­ces­sor

Last year
Peer Review

Au­rinia will ex­plore pos­si­ble sale, fol­low­ing push by share­hold­er

Last year
Deals
Pharma

Judge in Astel­las patent suit de­nies mo­tion to bol­ster de­fen­dant’s case

Last year
Pharma
Law

Liq­uidia and Unit­ed Ther­a­peu­tics could bring new lung in­di­ca­tion in­to le­gal saga

Last year
R&D

'Con­tin­ue lay­ing gold­en eggs!': Phar­ma ex­ec, doc­tors charged by SEC for al­leged in­sid­er trad­ing around ...

Last year
People
Law

Alvotech re­ceives an­oth­er CRL from the FDA for Hu­mi­ra biosim­i­lar can­di­date

Last year
Pharma
FDA+

FTC and DOJ pro­pose changes that could slow deal­mak­ing re­view process

Last year
Deals
Pharma

As it search­es for a new CEO, Il­lu­mi­na faces a high-stakes year of chal­lenges

Last year
People
R&D

Up­dat­ed: Bio­Marin’s he­mo­phil­ia A gene ther­a­py Roc­ta­vian wins FDA ap­proval af­ter de­lay and re­jec­tion, priced at ...

Last year
Pharma
FDA+

Man­u­fac­tur­ing roundup: Finnish phar­ma Ori­on in­vest­ing $30M+ to boost pro­duc­tion; Biosyn­gen opens new Sin­ga­pore ...

Last year
Manufacturing

BioX­cel stock craters af­ter dis­clo­sure of in­ves­ti­ga­tor's fal­si­fied safe­ty re­port in Alzheimer's study

Last year
R&D

Saris­sa and Alex Den­ner lose fight for board seats at Alk­er­mes

Last year
People

Fu­ji­film Diosynth names Lars Pe­tersen to re­place Mar­tin Mee­son as CEO

Last year
People
Manufacturing

Eiger Bio­Phar­ma­ceu­ti­cals to fo­cus on GLP-1 can­di­date, cut work­force by 25%

Last year
People
R&D

Aldeyra eyes po­ten­tial­ly piv­otal tri­al in re­tini­tis pig­men­tosa af­ter small open-la­bel read­out

Last year
R&D

Re­genxbio, UPenn file patent suit against Sarep­ta re­lat­ed to new Duchenne gene ther­a­py

Last year
Law

Eli Lil­ly to buy di­a­betes cell ther­a­py part­ner Sig­ilon, ex­pand­ing bet on pre­clin­i­cal pro­gram

Last year
Deals
Pharma

Tout­ing pro­grams from No­var­tis, Laek­na bags $100M in Hong Kong IPO while Mer­ck-part­nered Kelun seeks up to $208M

Last year
Financing
China
First page Previous page 318319320321322323324 Next page Last page
A service from the Financial Times